Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Boeing
BA
|
+$936M |
| 2 |
Amazon
AMZN
|
+$702M |
| 3 |
UnitedHealth
UNH
|
+$685M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$674M |
| 5 |
Bank of America
BAC
|
+$633M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$536M |
| 3 |
Tesla
TSLA
|
+$509M |
| 4 |
Citigroup
C
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$434M |
Sector Composition
| 1 | Healthcare | 16.72% |
| 2 | Technology | 15.86% |
| 3 | Financials | 11.72% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Timothy Plan US Large/Mid Cap Core Enhanced ETF
TPLE
$17.8M
| $918K | ﹤0.01% |
+35,916
| New | +$918K |
|
3302
Horizon Bancorp
HBNC
$863M
| $914K | ﹤0.01% |
56,763
-62,013
| -52% | -$999K |
|
3303
Sight Sciences
SGHT
$193M
| $914K | ﹤0.01% |
251,148
+136,448
| +119% | +$497K |
|
3304
Mercantile Bank Corp
MBWM
$785M
| $914K | ﹤0.01% |
20,541
+11,990
| +140% | +$533K |
|
|
CGTL
3305
Creative Global Technology Holdings
CGTL
$12.2M
| $914K | ﹤0.01% |
+114,332
| New | +$914K |
|
3306
iShares iBonds Oct 2031 Term TIPS ETF
IBIH
$29.3M
| $913K | ﹤0.01% |
+36,365
| New | +$913K |
|
3307
Angi Inc
ANGI
$803M
| $913K | ﹤0.01% |
55,019
+26,138
| +91% | +$434K |
|
3308
Upbound Group
UPBD
$1.58B
| $913K | ﹤0.01% |
31,295
-167,394
| -84% | -$4.88M |
|
|
BCIL
3309
Bancreek International Large Cap ETF
BCIL
$34.3M
| $913K | ﹤0.01% |
+36,168
| New | +$913K |
|
3310
NeoGenomics
NEO
$1.11B
| $913K | ﹤0.01% |
55,381
+36,155
| +188% | +$596K |
|
3311
MGP Ingredients
MGPI
$588M
| $912K | ﹤0.01% |
23,172
-38,713
| -63% | -$1.52M |
|
|
UTRN
3312
DELISTED
Vesper US Large Cap Short-Term Reversal Strategy ETF
UTRN
| $912K | ﹤0.01% |
30,070
+1
| +0% | +$30 |
|
3313
Enanta Pharmaceuticals
ENTA
$168M
| $910K | ﹤0.01% |
158,258
-514,622
| -76% | -$2.96M |
|
|
FLIC
3314
DELISTED
First of Long Island Corp
FLIC
| $909K | ﹤0.01% |
77,799
-7,322
| -9% | -$85.5K |
|
3315
Arbutus Biopharma
ABUS
$847M
| $908K | ﹤0.01% |
277,559
-330,185
| -54% | -$1.08M |
|
3316
First Trust Europe AlphaDEX Fund
FEP
$342M
| $907K | ﹤0.01% |
+25,329
| New | +$907K |
|
3317
SPDR S&P Software & Services ETF
XSW
$496M
| $907K | ﹤0.01% |
4,799
-2,512
| -34% | -$475K |
|
3318
VanEck Biotech ETF
BBH
$353M
| $907K | ﹤0.01% |
5,776
-16,038
| -74% | -$2.52M |
|
3319
Telefônica Brasil
VIV
$20.3B
| $906K | ﹤0.01% |
120,005
+92,938
| +343% | +$702K |
|
3320
S&T Bancorp
STBA
$1.53B
| $906K | ﹤0.01% |
23,700
+4,809
| +25% | +$184K |
|
3321
ProShares UltraShort Russell2000
TWM
$31.8M
| $904K | ﹤0.01% |
20,346
-24,734
| -55% | -$1.1M |
|
3322
Franklin Income Focus ETF
INCM
$826M
| $904K | ﹤0.01% |
+34,634
| New | +$904K |
|
3323
DNP Select Income Fund
DNP
$3.7B
| $903K | ﹤0.01% |
102,431
+81,424
| +388% | +$718K |
|
3324
Liberty Live Group Series A
LLYVA
$8.73B
| $903K | ﹤0.01% |
+13,572
| New | +$903K |
|
3325
iShares MSCI Switzerland ETF
EWL
$1.32B
| $903K | ﹤0.01% |
19,654
-24,898
| -56% | -$1.14M |
|